A Novel Classifier Based on Urinary Proteomics for Distinguishing Between Benign and Malignant Ovarian Tumors.
Source check: Source checked. Not independent scientific confirmation.
Finding: The primary study reports diagnostic discrimination for the classifier on its tumor cohort. External prospective performance and clinical benefit are not established.
Technology: Machine-learning analysis of urinary-proteomics profiles classified ovarian tumors as benign or malignant.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Machine-learning analysis of urinary-proteomics profiles classified ovarian tumors as benign or malignant.
- Test and result
- The primary study reports diagnostic discrimination for the classifier on its tumor cohort.
- Limitation / still unknown
- External prospective performance and clinical benefit are not established.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC8437375/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.